| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $8.1M | — | +296.4% |
| Cost of Revenue | $5.4M | — | +252.1% |
| Gross Profit | $2.7M | — | +434.2% |
| R&D Expense | $91K | — | +1053.3% |
| SG&A Expense | $7.2M | — | +124.1% |
| Operating Income | -$7.3M | — | -122.1% |
| Pre-tax Income | $10.3M | — | +414.8% |
| Income Tax | $0 | — | — |
| Net Income | $10.3M | — | +414.8% |
| EPS (Basic) | $0.22 | — | +204.8% |
| EPS (Diluted) | $0.21 | — | +200.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $222.9M | +115.9% | +4358.2% |
| Accounts Receivable | $3.1M | +100.0% | +6041.1% |
| Inventory | $13.8M | +160.1% | +1038.7% |
| Current Assets | $315.2M | +97.6% | +4214.1% |
| Total Assets | $339.7M | +85.9% | +1865.8% |
| Current Liabilities | $2.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$17.4M | — | -1358.8% |
| Capital Expenditures | $698K | — | — |
| Investing Cash Flow | -$5.4M | — | — |
| Financing Cash Flow | $142.5M | — | +5745.6% |
| Free Cash Flow | -$18.1M | — | -1417.3% |
| +134.5% |
| Total Liabilities | $8.1M | +3.8% | +482.2% |
| Stockholders' Equity | $331.6M | +89.6% | +1986.4% |